Dana B. Walker

1.1k total citations
26 papers, 770 citations indexed

About

Dana B. Walker is a scholar working on Small Animals, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Dana B. Walker has authored 26 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Small Animals, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in Dana B. Walker's work include Animal testing and alternatives (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Acute Myocardial Infarction Research (5 papers). Dana B. Walker is often cited by papers focused on Animal testing and alternatives (6 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Acute Myocardial Infarction Research (5 papers). Dana B. Walker collaborates with scholars based in United States, United Kingdom and Switzerland. Dana B. Walker's co-authors include Malcolm J. York, Rick L. Cowell, Syril Pettit, Brian R. Berridge, Stuart L. Shalat, Richard H. Finnell, William J. Reagan, Fred S. Apple, John P. Hoover and Jennifer E. Mersereau and has published in prestigious journals such as Blood, Clinical Chemistry and Fertility and Sterility.

In The Last Decade

Dana B. Walker

25 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana B. Walker United States 16 226 115 113 91 88 26 770
Ingrid Pruimboom‐Brees United States 11 161 0.7× 166 1.4× 25 0.2× 54 0.6× 114 1.3× 15 751
Johannes H. Harleman Germany 15 30 0.1× 113 1.0× 42 0.4× 197 2.2× 63 0.7× 36 693
W. Haider Germany 20 196 0.9× 173 1.5× 28 0.2× 47 0.5× 78 0.9× 78 1.2k
Jacek Michałkiewicz Poland 20 123 0.5× 268 2.3× 81 0.7× 19 0.2× 102 1.2× 74 1.1k
D. R. Bangham United Kingdom 19 139 0.6× 205 1.8× 88 0.8× 43 0.5× 55 0.6× 62 1.2k
Yoko Kashida Japan 16 47 0.2× 296 2.6× 43 0.4× 32 0.4× 113 1.3× 46 739
Joanna Matowicka-Karna Poland 20 85 0.4× 258 2.2× 46 0.4× 6 0.1× 281 3.2× 88 1.2k
Merve Savaş Türkiye 14 26 0.1× 91 0.8× 10 0.1× 72 0.8× 52 0.6× 46 771
Yuen Tan China 18 231 1.0× 436 3.8× 202 1.8× 6 0.1× 146 1.7× 41 1.4k
Jimyung Kim South Korea 18 109 0.5× 173 1.5× 87 0.8× 4 0.0× 50 0.6× 75 1.1k

Countries citing papers authored by Dana B. Walker

Since Specialization
Citations

This map shows the geographic impact of Dana B. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana B. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana B. Walker more than expected).

Fields of papers citing papers by Dana B. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana B. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana B. Walker. The network helps show where Dana B. Walker may publish in the future.

Co-authorship network of co-authors of Dana B. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Dana B. Walker. A scholar is included among the top collaborators of Dana B. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana B. Walker. Dana B. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Baran, Szczepan W., Ayan Das Gupta, Maria Lim, et al.. (2020). Continuous, Automated Breathing Rate and Body Motion Monitoring of Rats With Paraquat-Induced Progressive Lung Injury. Frontiers in Physiology. 11. 569001–569001. 7 indexed citations
3.
Walker, Dana B. & Susan Smith. (2017). Session Overview: Bone as an Endocrine Organ. Toxicologic Pathology. 45(7). 884–886. 1 indexed citations
4.
Reagan, William J., et al.. (2013). Comparison of Cardiac Troponin I and T, Including the Evaluation of an Ultrasensitive Assay, as Indicators of Doxorubicin-induced Cardiotoxicity. Toxicologic Pathology. 41(8). 1146–1158. 63 indexed citations
5.
Berridge, Brian R., Peter Hoffmann, James R. Turk, et al.. (2012). Integrated and translational nonclinical in vivo cardiovascular risk assessment: Gaps and opportunities. Regulatory Toxicology and Pharmacology. 65(1). 38–46. 12 indexed citations
6.
Schultze, A. Eric, Dana B. Walker, James R. Turk, et al.. (2012). Current Practices in Preclinical Drug Development. Toxicologic Pathology. 41(3). 445–453. 21 indexed citations
7.
Dillon, Katherine, Mary D. Sammel, Maureen Prewitt, et al.. (2012). Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertility and Sterility. 99(2). 477–483.e1. 102 indexed citations
8.
Reagan, William J., Armando R. Irizarry‐Rovira, Anne Provencher Bolliger, et al.. (2011). Best practices for evaluation of bone marrow in nonclinical toxicity studies. Veterinary Clinical Pathology. 40(2). 119–134. 19 indexed citations
9.
Newby, L. Kristin, Ignacio Rodríguez, John K. Finkle, et al.. (2011). Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity. American Heart Journal. 162(1). 64–73. 28 indexed citations
10.
Ennulat, Daniela, Dana B. Walker, Michal Magid-Slav, et al.. (2010). Effects of Hepatic Drug-metabolizing Enzyme Induction on Clinical Pathology Parameters in Animals and Man. Toxicologic Pathology. 38(5). 810–828. 63 indexed citations
11.
Clements, Peter, S.F. Brady, Malcolm J. York, et al.. (2010). Time Course Characterization of Serum Cardiac Troponins, Heart Fatty Acid–binding Protein, and Morphologic Findings With Isoproterenol-induced Myocardial Injury in the Rat. Toxicologic Pathology. 38(5). 703–714. 58 indexed citations
13.
Apple, Fred S., MaryAnn M Murakami, Ranka Ler, Dana B. Walker, & Malcolm J. York. (2008). Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury. Clinical Chemistry. 54(12). 1982–1989. 67 indexed citations
15.
MacAllister, Charles G., et al.. (1997). Haematology and serum biochemistry evaluation in normal postpartum mares. Equine Veterinary Journal. 29(3). 234–235. 10 indexed citations
16.
Walker, Dana B., K. R. Pierce, & Laura Boone. (1997). A 4‐Year‐Old Male Dachshund. Veterinary Clinical Pathology. 26(2). 71–71. 1 indexed citations
17.
Shalat, Stuart L., Dana B. Walker, & Richard H. Finnell. (1996). ROLE OF ARSENIC AS A REPRODUCTIVE TOXIN WITH PARTICULAR ATTENTION TO NEURAL TUBE DEFECTS. Journal of Toxicology and Environmental Health. 48(3). 253–272. 61 indexed citations
18.
Walker, Dana B. & Rick L. Cowell. (1995). Survival of a domestic cat with naturally acquired cytauxzoonosis. Journal of the American Veterinary Medical Association. 206(9). 1363–1365. 39 indexed citations
19.
Hoover, John P., et al.. (1994). Cytauxzoonosis in cats: Eight cases (1985–1992). Journal of the American Veterinary Medical Association. 205(3). 455–460. 46 indexed citations
20.
Walker, Dana B., et al.. (1993). Carcinoma in the Urinary Bladder of a Cat: Cytologic Findings and a Review of the Literature. Veterinary Clinical Pathology. 22(4). 103–108. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026